Results 221 to 230 of about 1,444,670 (278)

Immune checkpoint inhibitor-induced cardiotoxicity: from immune mechanisms to clinical surveillance and targeted therapies. [PDF]

Front Cardiovasc Med
Chen NK, Hok KD, Chokshi N, Shadid A, Rich HE, Gunamalai L, Doursout MF, Banda NK, Shivshankar P.   +8 more
europepmc   +1 more source

Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

J Pers Med
Katic J, Bulum T, Borovac JA.
europepmc   +1 more source

DUSP1 Inhibits Mechanotransduction and MAPK Signalling to Alleviate Myocardial Cell Hypertrophy. [PDF]

Clin Exp Pharmacol Physiol
Zhong X, Kong L, Zhang Y, Li J, Guan S, Qu X.   +5 more
europepmc   +1 more source

Cardiac myosin inhibitors in hypertrophic cardiomyopathy: gaps in knowledge and future opportunities

Shanghai Chest
Mehran Rahimi, Monica Ahluwalia, Ralf Martz Sulague, Jacques Kpodonu   +3 more
openaire   +1 more source

Genetic Determinants of Autoimmune Myocarditis: From Candidate Genes to GWAS Insights. [PDF]

Genes (Basel)
Pirzadah H, Ibrahim Z, Pirzadah Y, Yusuf N.   +3 more
europepmc   +1 more source

Stem Cell-Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions. [PDF]

J Am Heart Assoc
Koskulu B, Ali T, Tetik-Altintop I, Villanueva C, Gomola M, McConnell BK.   +5 more
europepmc   +1 more source

Establishment and Validation of a Stability-Indicating RP-HPLC Protocol for Mavacamten in Oral Capsule Preparations. [PDF]

Turk J Pharm Sci
Daroi PA, Patil P, Munipalli V, Sonawane B.   +3 more
europepmc   +1 more source

Evidence for a role of adverse sarcomere signaling in atrial fibrillation induction. [PDF]

J Mol Cell Cardiol Plus
McCauley MD, Solaro RJ.
europepmc   +1 more source

Small Molecules to Treat Cardiovascular Disease: Cardiac Myosin Inhibitors

Cardiovascular Innovations and Applications
openaire   +1 more source